Literature DB >> 11756983

Interrelationships among human immunodeficiency virus type 1 infection, bacterial vaginosis, trichomoniasis, and the presence of yeasts.

Prashini Moodley1, Cathy Connolly, A Willem Sturm.   

Abstract

Vaginal discharge of mixed etiology occurs frequently, with abnormal vaginal flora being the most common condition. The interrelationships among the disturbance of the vaginal ecology, the presence of yeasts, and infection with Trichomonas vaginalis and human immunodeficiency virus type 1 (HIV-1) were investigated among women presenting to a sexually transmitted diseases service. Analysis was done for 598 women. Although the prevalence of HIV-1 infection increased linearly with increasing Nugent's score (bacterial vaginosis score of Gram stain), the prevalence of T. vaginalis increased suddenly, from 12% in patients with a Nugent's score of < or =3 to 33% in patients with a score of 4, and remained at this level at higher scores. Yeast colonization and vulvovaginal candidiasis were inversely related to Nugent's scores. T. vaginalis might be responsible for the change in normal vaginal flora and may, therefore, be one of the causes of bacterial vaginosis. This could lead to more effective HIV-1 acquisition.

Entities:  

Mesh:

Year:  2001        PMID: 11756983     DOI: 10.1086/338027

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  60 in total

1.  Prevalence of bacterial vaginosis and Candida among postmenopausal women in the United States.

Authors:  Joscelyn N Hoffmann; Hannah M You; E C Hedberg; Jeanne A Jordan; Martha K McClintock
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2014-11       Impact factor: 4.077

2.  The influence of bacterial vaginosis on the response to Trichomonas vaginalis treatment among HIV-infected women.

Authors:  Megan Gatski; David H Martin; Judy Levison; Leandro Mena; Rebecca A Clark; Mary Murphy; Harold Henderson; Norine Schmidt; Patricia Kissinger
Journal:  Sex Transm Infect       Date:  2011-01-29       Impact factor: 3.519

3.  Severity of bacterial vaginosis and the risk of sexually transmitted infection.

Authors:  Jenifer E Allsworth; Jeffrey F Peipert
Journal:  Am J Obstet Gynecol       Date:  2011-02-27       Impact factor: 8.661

4.  Trichomonas vaginalis infection: can we afford to do nothing?

Authors:  R Scott McClelland
Journal:  J Infect Dis       Date:  2008-02-15       Impact factor: 5.226

5.  Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis.

Authors:  David N Fredricks; Tina L Fiedler; Katherine K Thomas; Brian B Oakley; Jeanne M Marrazzo
Journal:  J Clin Microbiol       Date:  2007-08-08       Impact factor: 5.948

Review 6.  Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies.

Authors:  Julius Atashili; Charles Poole; Peter M Ndumbe; Adaora A Adimora; Jennifer S Smith
Journal:  AIDS       Date:  2008-07-31       Impact factor: 4.177

7.  Mixed vaginitis-more than coinfection and with therapeutic implications.

Authors:  Jack D Sobel; Chitra Subramanian; Betsy Foxman; Marilyn Fairfax; Scott E Gygax
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

Review 8.  Global prevalence of Trichomonas vaginalis among female sex workers: a systematic review and meta-analysis.

Authors:  Monirsadat Mirzadeh; Aida Vafae Eslahi; Meysam Olfatifar; Amir Abdoli; Elham Houshmand; Hamidreza Majidiani; Morteza Ghanbari Johkool; Setareh Askari; Sima Hashemipour; Milad Badri
Journal:  Parasitol Res       Date:  2021-06-25       Impact factor: 2.289

9.  DNA fingerprinting of Lactobacillus crispatus strain CTV-05 by repetitive element sequence-based PCR analysis in a pilot study of vaginal colonization.

Authors:  May A D Antonio; Sharon L Hillier
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

10.  CD57 expression by T cells in the female genital tract of HIV-zx1 infected women.

Authors:  Lenine J Liebenberg; Adebayo Lawrence Adedeji; Darren P Martin; Pam P Gumbi; Lynette Denny; Jo-Ann S Passmore
Journal:  Clin Immunol       Date:  2010-01-25       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.